ID   VLN3G2
AC   CVCL_8009
DR   CLO; CLO_0009540
DR   ATCC; HB-8636
DR   BioSample; SAMN03471084
DR   Wikidata; Q54993204
RX   Patent=US4761377;
RX   PubMed=3621203;
RX   PubMed=3721525;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8636.
CC   Monoclonal antibody isotype: IgG1, kappa (PubMed=3621203); IgG4 (ATCC=HB-8636).
CC   Monoclonal antibody target: Human 68 kDa antigen on cell surface of A-431.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST   Source(s): ATCC=HB-8636
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,12,13
ST   D5S818: 11,12,13
ST   D7S820: 9,10,11,14
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
RX   Patent=US4761377;
RA   Glassy M.C., Surh C.D.;
RT   "Human-human hybrid cell lines that produce antibodies against
RT   antigenic determinants on cancer cells.";
RL   Patent number US4761377, 02-Aug-1988.
//
RX   PubMed=3621203;
RA   Glassy M.C.;
RT   "Immortalization of human lymphocytes from a tumor-involved lymph
RT   node.";
RL   Cancer Res. 47:5181-5188(1987).
//
RX   PubMed=3721525; DOI=10.1089/hyb.1986.5.93;
RA   Gaffar S.A., Surh C.D., Glassy M.C.;
RT   "Variations in the secretion of monoclonal antibodies by human-human
RT   hybridomas.";
RL   Hybridoma 5:93-105(1986).
//